loadpatents
Patent applications and USPTO patent grants for Maheswaran; Shyamala.The latest application filed is for "biomarkers of cancer".
Patent | Date |
---|---|
Methods relating to circulating tumor cell clusters and the treatment of cancer Grant 11,421,233 - Aceto , et al. August 23, 2 | 2022-08-23 |
Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers Grant 11,371,101 - Haber , et al. June 28, 2 | 2022-06-28 |
Biomarkers of Cancer App 20220098678 - Ting; David Tsai ;   et al. | 2022-03-31 |
Biomarkers of cancer Grant 11,142,800 - Ting , et al. October 12, 2 | 2021-10-12 |
Diagnosis and monitoring treatment of prostate cancer Grant 11,079,383 - Haber , et al. August 3, 2 | 2021-08-03 |
Digital Analysis of Circulating Tumor Cells in Blood Samples App 20210189501 - Haber; Daniel A. ;   et al. | 2021-06-24 |
Methods And Assays Relating To Circulating Tumor Cells App 20210130910 - TING; David T. ;   et al. | 2021-05-06 |
Methods and assays relating to circulating tumor cells Grant 10,900,083 - Ting , et al. January 26, 2 | 2021-01-26 |
LNA-based mutant enrichment next-generation sequencing assays Grant 10,876,151 - Sundaresan , et al. December 29, 2 | 2020-12-29 |
Methods Relating To Circulating Tumor Cell Clusters And The Treatment Of Cancer App 20200392505 - ACETO; Nicola ;   et al. | 2020-12-17 |
Methods relating to circulating tumor cell clusters and the treatment of cancer Grant 10,731,162 - Aceto , et al. | 2020-08-04 |
Targeting Human Satellite Ii (hsatii) App 20200017856 - Ting; David T. ;   et al. | 2020-01-16 |
Digital Analysis of Blood Samples to Determine Efficacy of Cancer Therapies for Specific Cancers App 20190391134 - Haber; Daniel ;   et al. | 2019-12-26 |
Targeting human satellite II (HSATII) Grant 10,301,624 - Ting , et al. | 2019-05-28 |
Methods Relating To Circulating Tumor Cell Clusters And The Treatment Of Cancer App 20180320185 - ACETO; Nicola ;   et al. | 2018-11-08 |
Cadherins as cancer biomarkers Grant 10,094,837 - Maheswaran , et al. October 9, 2 | 2018-10-09 |
Methods relating to circulating tumor cell clusters and the treatment of cancer Grant 10,053,692 - Aceto , et al. August 21, 2 | 2018-08-21 |
LNA-Based Mutant Enrichment Next-Generation Sequencing Assays App 20180112259 - Sundaresan; Tilak K. ;   et al. | 2018-04-26 |
Digital Analysis of Circulating Tumor Cells in Blood Samples App 20180057889 - Haber; Daniel A. ;   et al. | 2018-03-01 |
Biomarkers of Cancer App 20170356054 - Ting; David Tsai ;   et al. | 2017-12-14 |
Diagnosis And Monitoring Treatement Of Prostate Cancer App 20170350896 - HABER; Daniel A. ;   et al. | 2017-12-07 |
Biomarkers of Cancer App 20170292942 - Ting; David Tsai ;   et al. | 2017-10-12 |
Diagnosis and monitoring treatment of prostate cancer Grant 9,766,244 - Haber , et al. September 19, 2 | 2017-09-19 |
Targeting Human Satellite Ii (hsatii) App 20170198288 - Ting; David T. ;   et al. | 2017-07-13 |
Cadherins as Cancer Biomarkers App 20160349264 - Maheswaran; Shyamala ;   et al. | 2016-12-01 |
Methods And Assays Relating To Circulating Tumor Cells App 20160312298 - TING; David T. ;   et al. | 2016-10-27 |
Methods Relating To Circulating Tumor Cell Clusters And The Treatment Of Cancer App 20160264973 - ACETO; Nicola ;   et al. | 2016-09-15 |
Cadherins as cancer biomarkers Grant 9,417,244 - Maheswaran , et al. August 16, 2 | 2016-08-16 |
Diagnosis And Monitoring Treatment Of Prostrate Cancer App 20150168413 - Haber; Daniel A. ;   et al. | 2015-06-18 |
Biomarkers of Cancer App 20140287956 - Ting; David Tsai ;   et al. | 2014-09-25 |
Cadherins as Cancer Biomarkers App 20140234869 - Maheswaran; Shyamala ;   et al. | 2014-08-21 |
Biomarkers of Cancer App 20140031250 - Ting; David Tsai ;   et al. | 2014-01-30 |
Use of mullerian inhibiting substance and interferon for treating tumors App 20040151693 - Maheswaran, Shyamala ;   et al. | 2004-08-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.